Assessing abuse liability in clinical trials
- 3 May 2003
- journal article
- review article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 70 (3) , S87-S95
- https://doi.org/10.1016/s0376-8716(03)00101-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Guidelines and methodological reviews concerning drug abuse liability assessmentDrug and Alcohol Dependence, 2003
- Principles of drug abuse liability assessment in laboratory animalsDrug and Alcohol Dependence, 2003
- Principles of initial experimental drug abuse liability assessment in humansDrug and Alcohol Dependence, 2003
- Postmarketing surveillance for drug abuseDrug and Alcohol Dependence, 2003
- A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United StatesDrug and Alcohol Dependence, 1999
- A NOVEL BAYESIAN DECISION PROCEDURE FOR EARLY-PHASE DOSE-FINDING STUDIESJournal of Biopharmaceutical Statistics, 1999
- The Pharmacokinetic Principles Behind Scaling from Preclinical Results to Phase I ProtocolsClinical Pharmacokinetics, 1999
- Testing Drugs for Physical Dependence Potential and Abuse Liability: NIDA Research Monograph 52Published by American Psychological Association (APA) ,1984
- Double-blind Evaluation of Reinforcing and Anorectic Actions of Weight Control MedicationsArchives of General Psychiatry, 1980
- Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in manClinical Pharmacology & Therapeutics, 1971